Home > References - Aspirin for the Primary...

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Wolff T, Miller T, Ko S. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Mar. (Evidence Syntheses, No. 68.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

References

1.
Thom T, Haase N, Rosamond W. et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–151. [PubMed: 16407573]
2.
Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of Stroke: A Risk Profile From the Framingham Study. Stroke. 1991;22:312–18. [PubMed: 2003301]
3.
U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002;136(2):157–60. [PubMed: 11790071]
4.
Ridker PM, Cook NR, Lee IM. et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352(13):1293–304. [PubMed: 15753114]
5.
Whitlock EP, Lin JS, Chou R, Shekelle P, Robinson KA. Using existing systematic reviews in complex systematic reviews. Ann Intern Med. 2008;148(10):776–82. [PubMed: 18490690]
6.
Harris R, Atkins D, Berg AO, Best D, et al. US Preventive Services Task Force Procedure manual Rockville, MD: Agency for Healthcare Research and Quality; 2001.
7.
Harris RP, Helfand M, Woolf SH. et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(Suppl 3):21–35. [PubMed: 11306229]
8.
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. Jama. 2006;295(3):306–13. [PubMed: 16418466]
9.
Peto R, Gray R, Collins R, Whealey K, Hennekens C, Jamrozik K. et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296(6618):313–6. [PMC free article: PMC2544821] [PubMed: 3125882]
10.
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321(3):129–35. [PubMed: 2664509]
11.
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet. 1998;351(9098):233–41. [PubMed: 9457092]
12.
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755–62. [PubMed: 9635947]
13.
de Gaetano G. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001;357(9250):89–95. [PubMed: 11197445]
14.
Zanchetti A, Hansson L, Dahlöf B, Julius S, Ménard J, Warnold I. HOT Study Group. et al. Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk. J Hypertens. 2002;20(11):2301–7. [PubMed: 12409970]
15.
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A. PPP Collaborative Group. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003;26(12):3264–72. [PubMed: 14633812]
Cover of Aspirin for the Primary Prevention of Cardiovascular Events
Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force [Internet].
Evidence Syntheses, No. 68.
Wolff T, Miller T, Ko S.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...